Enoxaparin Sodium Injection, Solution
Product Images NDC 70710-1761

Product Visual Gallery

This gallery contains 31 technical images submitted to the FDA as part of the official labeling for Enoxaparin Sodium (NDC 70710-1761). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure A (55ef96d3 0a46 45ee Bb42 D2d23f76a80a 01)

An instructional illustration showing two hands pulling apart a syringe and its needle cap, with a double-headed arrow indicating separation. This image demonstrates how to remove the needle cap before using the Enoxaparin Sodium injection solution.*

FDA Label Image

Figure B (55ef96d3 0a46 45ee Bb42 D2d23f76a80a 02)

An instructional illustration showing a hand injecting Enoxaparin Sodium into the lower arm or forearm area using a syringe. The image demonstrates subcutaneous administration technique with an arrow indicating the direction of the injection.*

FDA Label Image

Figure C (55ef96d3 0a46 45ee Bb42 D2d23f76a80a 03)

An instructional illustration showing a hand administering an Enoxaparin Sodium injection subcutaneously into a patient's abdomen. The syringe is held at an angle with the needle inserted into the skin, with an arrow indicating the direction of injection.*

FDA Label Image

Figure D (55ef96d3 0a46 45ee Bb42 D2d23f76a80a 04)

An instructional illustration showing a hand holding a syringe with Enoxaparin Sodium injection solution. The image demonstrates the proper technique to remove or handle the syringe cap by pulling it in the direction indicated by a bold arrow.*

FDA Label Image

Figure E (55ef96d3 0a46 45ee Bb42 D2d23f76a80a 05)

An instructional illustration showing a gloved hand disposing of a used syringe into a biohazard sharps container marked with a biohazard symbol. The arrow indicates the syringe being inserted into the container.*

FDA Label Image

Structural Formula (55ef96d3 0a46 45ee Bb42 D2d23f76a80a 06)

Chemical structure diagram depicting the molecular structure of Enoxaparin Sodium, showing repeating units with annotations for variable groups R1 and R2 representing hydrogen, sodium sulfate, or acetyl groups as part of the polymer chain.*

FDA Label Image

Structural Formula 2 (55ef96d3 0a46 45ee Bb42 D2d23f76a80a 07)

Chemical structure diagram showing a molecular formula with variables R, X*, n, and functional groups including COONa, OH, OR1, and NHSO3Na. This represents the chemical structure of Enoxaparin Sodium as described in the image.*

FDA Label Image

Figure 1 (55ef96d3 0a46 45ee Bb42 D2d23f76a80a 08)

A forest plot chart comparing relative risks of outcomes across various subgroups related to Enoxaparin Sodium and unfractionated heparin (UFH). The chart shows subgroups by sex, age, infarct location, diabetes status, prior myocardial infarction, fibrinolytic agent type, time to treatment, and PCI within 30 days. It lists number of patients, relative risk values, percentage reductions for UFH and Enoxaparin, and risk reduction percentages, illustrating treatment efficacy comparisons.*

FDA Label Image

Figure 2 (55ef96d3 0a46 45ee Bb42 D2d23f76a80a 09)

A Kaplan-Meier curve comparing the hazard distribution function for Enoxaparin Sodium injection solution versus UFH (unfractionated heparin) over 30 days regarding time to death or myocardial re-infarction. The x-axis shows days, and the y-axis shows hazard distribution. An inset graph displays the data specifically at 1 year. The chart includes numbers at risk for each group at various time points and p-values from log-rank tests indicating statistical comparison.*

FDA Label Image

Enoxa-ifu-image01 (55ef96d3 0a46 45ee Bb42 D2d23f76a80a 10)

An instructional diagram showing the Enoxaparin Sodium injection syringe before and after use. The 'Before Use' side labels the plunger rod, needle, and needle cap, while the 'After Use' side shows the plunger rod and a protective sleeve covering the needle, illustrating safe disposal or handling after injection.*

FDA Label Image

Enoxa-ifu-imagea (55ef96d3 0a46 45ee Bb42 D2d23f76a80a 11)

An instructional illustration showing components for Enoxaparin Sodium injection administration, including a prefilled syringe of Enoxaparin Sodium, a cotton ball or gauze, an alcohol wipe, a small adhesive bandage, and a sharps disposal container.*

FDA Label Image

Enoxa-ifu-image B (55ef96d3 0a46 45ee Bb42 D2d23f76a80a 12)

An instructional illustration showing hands preparing a prefilled syringe for use, likely peeling back a protective covering from the syringe prior to injection. This image is associated with Enoxaparin Sodium injection solution handling instructions.*

FDA Label Image

Enoxa-ifu-image C (55ef96d3 0a46 45ee Bb42 D2d23f76a80a 13)

The image shows a prefilled syringe of Enoxaparin Sodium injection, solution. The syringe is labeled with dosage information and includes a marked expiration date section. The product is intended for intravenous or subcutaneous administration and is manufactured by Zydus Pharmaceuticals USA Inc.*

FDA Label Image

Enoxa-ifu-image D (55ef96d3 0a46 45ee Bb42 D2d23f76a80a 14)

Illustration of a pre-filled syringe labeled as containing a clear liquid, representing an injection solution. The syringe includes a plunger, barrel, and needle cap, indicative of a parenteral medication delivery device.*

FDA Label Image

Enoxa-ifu-image E (55ef96d3 0a46 45ee Bb42 D2d23f76a80a 15)

An instructional illustration showing the abdominal area with two rectangular shaded regions on each side of the navel, indicating potential injection sites for subcutaneous administration of Enoxaparin Sodium injection.*

FDA Label Image

Enoxa-ifu-image F (55ef96d3 0a46 45ee Bb42 D2d23f76a80a 16)

An instructional illustration showing a hand holding a small square swab and preparing to clean an injection site on the lower abdomen, likely demonstrating site preparation for subcutaneous injection.*

FDA Label Image

Enoxa-ifu-image H (55ef96d3 0a46 45ee Bb42 D2d23f76a80a 17)

An instructional illustration showing two hands preparing a syringe. One hand holds the syringe, while the other is removing or placing the protective cap from the needle, indicated by double-headed arrows suggesting the movement direction.*

FDA Label Image

Enoxa-ifu-image H (55ef96d3 0a46 45ee Bb42 D2d23f76a80a 18)

An instructional diagram showing a hand holding a prefilled syringe, illustrating the step to set the dose by adjusting the plunger to align with a marked dosage level on the syringe barrel, indicated by a dashed line and an arrow pointing downward. The text 'Set your dose' appears next to the dashed line.*

FDA Label Image

Enoxa-ifu-image I (55ef96d3 0a46 45ee Bb42 D2d23f76a80a 19)

Instructional illustration showing a hand pinching the skin on the side of the body, demonstrating a method for administering a subcutaneous injection. This image is likely related to the injection use of Enoxaparin Sodium solution.*

FDA Label Image

Enoxa-ifu-image J (55ef96d3 0a46 45ee Bb42 D2d23f76a80a 20)

An instructional diagram showing a hand holding a syringe at a 90-degree angle to the skin, preparing for a subcutaneous injection. The image depicts the correct positioning of the syringe and needle for administering an injection, relevant to Enoxaparin Sodium injection use.*

FDA Label Image

Enoxa-ifu-image K (55ef96d3 0a46 45ee Bb42 D2d23f76a80a 21)

Illustration showing the administration of an injection into the abdominal area. One hand is holding an injection syringe positioned to inject subcutaneously, with the other hand pinching the skin. An arrow indicates the direction of injection toward the skin fold.*

FDA Label Image

Enoxa-ifu-image L (55ef96d3 0a46 45ee Bb42 D2d23f76a80a 22)

An instructional illustration showing a hand holding a syringe ready to inject into the abdomen, indicated by a thumb pointing to the injection site on the lower abdomen. The image demonstrates the technique for subcutaneous injection, relevant to Enoxaparin Sodium injection administration.*

FDA Label Image

Enoxa-ifu-image M (55ef96d3 0a46 45ee Bb42 D2d23f76a80a 23)

Illustration showing a hand holding a syringe with a protective sleeve labeled. An arrow points to the syringe cap with the word 'CLICK' indicating how to remove the cap or activate the device.*

FDA Label Image

Enoxa-ifu-image N (55ef96d3 0a46 45ee Bb42 D2d23f76a80a 24)

An instructional illustration showing the disposal process of an Enoxaparin Sodium syringe with needle cap into a sharps disposal container. A hand is depicted holding the syringe above the container labeled 'Sharps Disposal Container.' The syringe and needle cap are clearly labeled in the diagram.*

FDA Label Image

Image (55ef96d3 0a46 45ee Bb42 D2d23f76a80a 25)

Packaging label for Enoxaparin Sodium Injection USP 30 mg/0.3 mL in single-dose syringes by Zydus Pharmaceuticals USA Inc. The label highlights the dosage strength, syringe volume, and intended use with an automatic safety device for subcutaneous injection, including administration instructions and storage information.*

FDA Label Image

Image (55ef96d3 0a46 45ee Bb42 D2d23f76a80a 26)

Packaging label for Enoxaparin Sodium Injection USP 40 mg/0.4 mL by Zydus Pharmaceuticals USA Inc. The label indicates single-dose syringes with an automatic safety device for subcutaneous injection. The carton contains ten 0.4 mL syringes and includes usage instructions and storage information. The label specifies that the product is for injection use only.*

FDA Label Image

Image (55ef96d3 0a46 45ee Bb42 D2d23f76a80a 27)

Packaging label for Enoxaparin Sodium Injection USP 60 mg/0.6 mL, a single-dose syringe solution for subcutaneous injection. The label indicates it is manufactured by Zydus Pharmaceuticals USA Inc and contains ten 0.6 mL syringes. The label includes dosing and usage instructions, storage conditions, and safety device information.*

FDA Label Image

Image (55ef96d3 0a46 45ee Bb42 D2d23f76a80a 28)

Packaging label for Enoxaparin Sodium Injection USP 80 mg/0.8 mL in single-dose syringes by Zydus Pharmaceuticals USA Inc. The label indicates the product is intended for subcutaneous injection and includes instructions and safety information. The package contains ten 0.8 mL syringes.*

FDA Label Image

Image (55ef96d3 0a46 45ee Bb42 D2d23f76a80a 29)

Packaging label for Enoxaparin Sodium Injection USP 100 mg/mL, a solution for injection by intravenous or subcutaneous routes. The label indicates single-dose syringes with an automatic safety device, contains ten 1 mL syringes, and is labeled by Zydus Pharmaceuticals USA Inc. The label includes usage instructions and storage information.*

FDA Label Image

Image (55ef96d3 0a46 45ee Bb42 D2d23f76a80a 30)

Packaging label for Enoxaparin Sodium Injection USP, 120 mg/0.8 mL, manufactured by Zydus Pharmaceuticals USA Inc. The label indicates single-dose syringes with an automatic safety device for subcutaneous injection. It includes product use directions and storage information with a barcode and regulatory details on the side panels.*

FDA Label Image

Image (55ef96d3 0a46 45ee Bb42 D2d23f76a80a 31)

Packaging label for Enoxaparin Sodium Injection USP 150 mg/mL by Zydus Pharmaceuticals USA Inc. The label indicates single-dose 1 mL syringes with an automatic safety device for subcutaneous injection, containing ten 1 mL syringes per pack. The front and sides of the carton display dosage strength, product name, manufacturer information, handling instructions, and usage directions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.